ArticleNeurology and therapy2026

Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.

Stefan Gingele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.